e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Translational studies in chronic lung diseases: from bedside to bench
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The reactive carbonyl derivatives of proteins in neutrophils of patients with varying severity of COPD
V. Molotov-Luchanskiy, L. Muravluyova, D. Kluyev (Karaganda, Kazakhstan)
Source:
Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Session:
Translational studies in chronic lung diseases: from bedside to bench
Session type:
Poster Discussion
Number:
257
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Molotov-Luchanskiy, L. Muravluyova, D. Kluyev (Karaganda, Kazakhstan). The reactive carbonyl derivatives of proteins in neutrophils of patients with varying severity of COPD. Eur Respir J 2013; 42: Suppl. 57, 257
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Enhanced neutrophil extracellular trap (NET) formation in sputum of stable COPD patients
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
Pro-and anti-fibrotic molecule balance in the bronchial mucosa of stable COPD patients
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Neutrophil numbers are decreased in bronchial biopsies from patients with COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Elevated mitochondrial reactive oxygen species in COPD macrophages at exacerbation
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Redox systems of neutrophils of patients with exacerbated COPD
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008
TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Methylated arginine derivatives can differ stable and unstable patients with COPD
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Fructosamine-3-Kinase: A molecular link between COPD and diabetes regulating carbonyl stress and the impact of metformin treatment
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Endothelial progenitor cells are dysfunctional in smokers and COPD patients due to increased DNA damage and senescence
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013
Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014
Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept